Residual Platelet Reactivity and Dyslipidemia in Post-CABG Patients Undergoing Repeat Revascularization: Insights from Kazakhstan
Residual platelet reactivity and dyslipidemia are common and clinically relevant predictors of repeat revascularization after CABG. Optimization of antiplatelet and lipid-lowering therapy should be prioritized in secondary prevention for this high-risk population. These findings are particularly important in Kazakhstan, where post-CABG management strategies warrant further improvement.
Authors
- Farida Rustamova (ORCID: https://orcid.org/0000-0002-5259-6171)
- Aisulu Mussagaliyeva
- Orazbek Sakhov (ORCID: https://orcid.org/0000-0002-8703-8743)
- Ш.Б. Жангелова (ORCID: https://orcid.org/0000-0003-3702-5642)
- D. A. Kapsultanova (ORCID: https://orcid.org/0000-0003-1449-4438)
- Akhmetzhan Sugraliyev (ORCID: https://orcid.org/0000-0002-8255-4159)
- Friba Nurmukhammad (ORCID: https://orcid.org/0000-0002-6312-4479)
- Laura Danyarova (ORCID: https://orcid.org/0000-0003-0143-3847)
- Dana Akhmentayeva (ORCID: https://orcid.org/0000-0001-9395-8397)
Institutions
- Kazakh National Medical University (KZ)
- Ahmet Yesevi University (KZ)
- Kazakh Institute of Oncology and Radiology (KZ)
Publication Details
- Journal
- Diseases
- Published
- 2025-11-09
- DOI
- https://doi.org/10.3390/diseases13110365
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00